Concepedia

Publication | Closed Access

LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial

DOI

16

Citations

0

References

2022

Year

John B.A.G. Haanen, M. Rohaan, T.H. Borch, J.H. van den Berg, Ö. Met, Marnix Geukes Foppen, J. Stoltenborg Granhøj, B. Nuijen, C. Nijenhuis, J.H. Beijnen,
Annals of Oncology

No additional data available for this publication yet. Check back later!